Abstract

Identification of the selective neurokinin NK 1 receptor antagonist, 2-( R)-(1-( R)-3,5-Bis(trifluromethyl)phenylethoxy)-3-( S)-(4-fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5yl)methylmor-phine (MK-869), as a novel therapeutic approach for anxiety/depression has led to increased use of the Mongolian gerbil in behavioural studies since the gerbil NK 1 receptor pharmacology is similar to human, but not rat or mouse. Within this species, foot tapping and immobility elicited by aversive conditioning, as well as social interaction have been shown to be sensitive to clinically used anxiolytic and antidepressant agents and also NK 1 receptor antagonists. The high levels of NK 1 receptor binding in the amygdala as well as preclinical studies demonstrating increased release of substance P and corresponding internalisation of NK 1 receptors in the basolateral amygdala in response to stressful stimuli suggest that the BLA may represent a potential site of action for NK 1 receptor antagonists in anxiety and/or depression. Therefore, in the current study, we assessed the effect of bilateral BLA lesions in male Mongolian gerbils on footshock-induced foot tapping and immobility, social interaction, and NK 1-agonist-induced foot tapping. Lesioned gerbils exhibited reduced immobility time during fear conditioning, a non-significant reduction in immobility time when re-exposed to the conditioned stimulus (CS) 24 h later, and increased social interaction in the gerbil social interaction task. In contrast, BLA lesions had no effect on NK 1-agonist-induced foot tapping. These data provide further support that the gerbil BLA is a potential site for NK 1 receptor antagonists to attenuate anxiety-related behaviours.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.